Summary

Leap Therapeutics

Founded in 2016

Description

Leap Therapeutics, Inc. (Nasdaq: LPTX) is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics for cancer patients. Their most advanced clinical candidate, DKN 01, is a humanized monoclonal antibody...

Strengths

  • There are no known strengths for Leap Therapeutics

Weaknesses

  • Leap Therapeutics has a very small market share in their industry
  • Revenue generated per employee is less than the industry average
  • Since Leap Therapeutics was founded, the company has experienced slower revenue growth than the industry average

Annual Revenue

Leap Therapeutics's annual revenue

$1125000

Based on Kona Equity data

  • Revenue per employee

    $31250

  • Annual revenue growth since founding

    $140625

Employee Count

36 employees

Executives

Asher Shamir

Controller

a**@leaptx.com

Christine Granfield

Quality Vice President, Regulatory

c**@leaptx.com

Douglas Onsi

President & Chief Executive Officer

d**@leaptx.com

Adam Connelly

Associate Director, CMC Analytical Development & Quality Control At Leap Therapeutics

a**@leaptx.com

Joaquina Mascarenhas

Associate Director, Upstream Process Development & Manufacturing

j**@leaptx.com

Augustine Lawlor

Chief Operating Officer

a**@leaptx.com

Mark Mahony

Manufacturing Chief & Officer

m**@leaptx.com

Jason Baum

Vice President and Head of Translational Medicine

j**@leaptx.com

Matthew Lederhos

Controller

m**@leaptx.com

Steve Tokatlyan

Associate Director, Information Technology

s**@leaptx.com

Cynthia Sirard

Chief Medical Officer

c**@leaptx.com

Phone Therapeutics

President & Chief Executive Officer

p**@leaptx.com

G Score - 0

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

Location

 
Cambridge, MA  02142

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Visterra , Inc.

visterrainc.com
  • Founded in 2007
  • Location: Waltham, Massachusetts
  • Annual Revenue: $18.9M
  • Employees: 53
  • Visterra is a biologics research and early stage clinical development company developing therapies for patients with immune mediated and other hard to treat diseases. Our proprietary technology platform enables the design and engineering of precision a...

Viking Therapeutics

vikingtherapeutics.com
  • Founded in 2012
  • Location: San Diego, CA
  • Annual Revenue: $4.4M
  • Employees: 21
  • Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-e…

Aravive

aravive.com
  • Founded in 2008
  • Location: Houston, TX
  • Annual Revenue: $8.3M
  • Employees: 23
  • [av_one_half first min_height='' vertical_alignment='' space='' custom_margin='' margin='0px' row_boxshadow='' row_boxshadow_color='' row_boxshadow_width='10' link='' linktarget='' link_hover='' title_attr='' alt_attr='' padding='0px'

Pliant Therapeutics Inc

pliantrx.com
  • Founded in 2015
  • Location: South San Francisco, CA
  • Annual Revenue: $6.6M
  • Employees: 101
  • Pliant is a biotechnology company focused on developing breakthrough treatments for fibrotic diseases. They are dedicated to bringing hope to patients with fibrosis through the discovery and development of novel therapies. Pliant's approach involves ta...

Neuraltus Pharmaceuticals

neuraltus.com
  • Founded in 2004
  • Location: San Bruno, CA
  • Annual Revenue: $3.5M
  • Employees: 18

Orphazyme

orphazyme.com
  • Founded in 2009
  • Location: Copenhagen', None
  • Annual Revenue: $5.1M
  • Employees: 62
  • Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients wit...

Key Information

  • SIC: 28; 283
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Leap Therapeutics.

See similar companies

Frequently Asked Questions

Where is Leap Therapeutics located?

Leap Therapeutics's headquarters are located at   Cambridge, MA  02142.


What is Leap Therapeutics's official website?

Leap Therapeutics's official website is leaptx.com


What is Leap Therapeutics's revenue?

Leap Therapeutics's annual revenue is $1.1 M.


What is Leap Therapeutics's SIC code?

Leap Therapeutics's SIC: 28; 283


How many employees does Leap Therapeutics's have?

Leap Therapeutics has 36 employees


What industry does Leap Therapeutics belong to?

Leap Therapeutics is in the industry of Pharmaceuticals.

Next step

Visitors review